IperionX Limited
Orin's own judgment of how firmly the evidence points one way — not the chance the price goes up.
IperionX remains a pre-revenue titanium critical minerals developer with net losses nearly doubling to -$67.1M in FY2026 (year ended 30 Jun) from -$35.3M in FY2025, yet the September 2026 GenX continuous titanium production validation and a second U.S.
Army SBIR task order in August 2026 provide a credible commercialization pathway. Strong insider conviction — a July 2026 cluster buy by five insiders totaling ~$2.6M and 24-month net insider buying of ~$8.1M with zero dispositions — supports the bull case, but an August 2026 fraud investigation, a September 2026 EPS miss of -$0.09 vs -$0.07 estimated, and the stock at $15.62 trading well below its 50-day MA of $20.66 and 200-day MA of $32.23 as of 12 Oct keep this a speculative binary outcome best held until revenue materializes.
What could go wrong
- Accelerating cash burn. Net loss widened from -$35.3M (FY2025) to -$67.1M (FY2026) with zero revenue; free cash flow was -$63.0M in the year ended 30 Jun, and stockholders' equity of $88.3M may not sustain the trajectory without dilutive raises.
- Fraud investigation overhang. An August 2026 securities fraud investigation by SBS Law was announced, creating legal uncertainty and potential reputational drag on the share price.
- Negligible institutional interest. Smart-money score of 0.00 with only 16 funds as of 30 Jun suggests minimal professional capital is allocated, limiting upside catalysts from flows.
- Operational execution risk. GenX continuous production has been validated but sustained furnace reliability and routine commercial-scale output are not yet demonstrated; the Seeking Alpha article from August 2026 notes these operational risks remain unresolved.
What would change my mind
Where this comes from: fundamentals, to 30 Jun · GlobeNewsWire, 16 Sep · GlobeNewsWire, 31 Aug · insider trades. Orin's read on IPX; not advice.
How has the share price moved?
Down 68.9% over twelve months, from $46.56 on 27 Oct 2025 to $14.50 at the Tue 27 Oct 2026 close. Its highest close in that time was $60.11 on 23 Jan 2026; the last close is 75.9% below it.
- Green line: the closing price each trading day.
- Grey line: the average closing price over the last 50 trading days.
- Dashed amber line: the same over the last 200 trading days — a slower, smoother line.
- Bars along the bottom: shares traded each day — green when it closed higher than the day before, rose when lower (the most, 1.2M, on 16 Mar 2026).
On file
All IPX filingsLargest holders · 13F Q2 2026
Money flow| Filer | Position | Of fund |
|---|---|---|
| Woodline Partners | $19.4M | 0.1% |
| Millennium Management | $17.2M | 0.0% |
| Tudor Investment | $2.4M | 0.0% |
| Point72 Asset Management | $2.0M | 0.0% |
| Morgan Stanley | $1.9M | 0.0% |
| BlackRock | $1.6M | 0.0% |
| Bank of America | $1.6M | 0.0% |
| Bank of Montreal | $919K | 0.0% |
| Goldman Sachs Group | $455K | 0.0% |
| Trexquant Investment | $350K | 0.0% |
16 of the 815 filers we track · quarter ended Q2 2026 · positions, not flows
Insiders, last 24 months: 30 Form 4 filings; open-market trades net $8.1M. Of the 30 on hand, 16 were open-market purchases and 0 sales — the rest are grants, option exercises and tax withholding.
Ask Orin about IPX
Orin answers questions about IPX from its filings, transcripts and numbers — with the source behind every claim. Your own desk starts with 3 free days, card required.
Start 3 free days →How is it priced, against its own past and its sector?
It lost money over the last 12 months, so it has no P/E (Tue 27 Oct close).
| Measure | Now | Its usual | Sector |
|---|---|---|---|
| P/E | lost money | — | 26.4× |
| P/S | no sales on file | — | — |
| P/B | 5.2× | — | — |
- P/E: lost money — no P/E over the last 12 months.
- P/S: no sales on file.
- P/B: no usual level — it ran from 1.1× to 10.5× over its last 5 fiscal years, so a middle value says little.
P/E: the share price divided by one year of profit per share — roughly how many years of today's profit the price pays for. A company that loses money has no P/E.
P/S: the company's total market value divided by one year of revenue. Used when there is no profit to measure.
EV/EBITDA: the price of the whole company (its shares plus its debt, minus its cash) divided by one year of operating profit before interest, tax and write-downs.
P/B: the share price divided by the book value per share — what the company owns minus what it owes, as its accounts record it. When book value is tiny, P/B swings wildly and says little.
What do the analysts who cover it publish?
The analysts' average 12-month price target is $44 (from $26 to $53) — 203% above the Tue 27 Oct close price. That is their published opinion, not Orin's.
$44
$26 – $53 · +203% against the last close
- 3 buy or overweight
- 0 hold
- 0 underweight or sell
Price target: the share price an analyst publishes for about 12 months ahead. It is the opinion of the firm that wrote it; the average is across the firms that cover the company.
Overweight / underweight: analysts' rating words: overweight means the firm expects the stock to do better than the others it covers, underweight worse. Their words, not Orin's.
How is it priced next to the companies it is compared to?
It lost money over the last 12 months, so it has no P/E. None of the 1 companies it is compared to made a profit, so there is no typical P/E.
| Company | Market value | P/E | EV/EBITDA | Gross margin | Net margin | ROE |
|---|---|---|---|---|---|---|
| IPXIperionX Limited | $487M | lost money | — | 0.0% | 0.0% | −68% |
| UECUranium Energy Corp. | $4B | lost money | n/m | −56.4% | −368.6% | −10% |
- UEC: lost money over the last 12 months, so no P/E.
- UEC: EV/EBITDA is not meaningful (n/m) — its cash exceeds its market value plus debt, or the business lost money before depreciation.
- The list of companies is the data vendor's choice, so it can include a company a person would not have picked.
Market value: the share price times the number of shares — what the whole company is priced at.
P/E: the share price divided by one year of profit per share — roughly how many years of today's profit the price pays for. A company that loses money has no P/E.
EV/EBITDA: the price of the whole company (its shares plus its debt, minus its cash) divided by one year of operating profit before interest, tax and write-downs.
Gross margin: the share of each $1 of sales left after the direct cost of making what was sold.
Net margin: the share of each $1 of sales kept as profit after every cost. Below zero, the company lost money.
ROE: return on equity: one year of profit as a share of the shareholders' money in the business (its book value).
Is it priced high or low compared with its own past?
It has lost money and has no full fiscal year on file since its history starts, so it has no P/E history.
- Nowlost money
- Now: no P/E — it lost money over the last 12 months.
P/E: the share price divided by one year of profit per share — roughly how many years of today's profit the price pays for. A company that loses money has no P/E.
Fiscal year (FY): the company's own 12-month accounting year, which need not match the calendar year.
How has its sector been priced?
Basic Materials companies on the NASDAQ were priced at a typical 26.4× their yearly profit (Tue 27 Oct close).
- Now26.4×
- Each year is the middle of that calendar year's daily sector P/E; "Now" is the Tue 27 Oct close figure, the same one in the table above.
Sector P/E: the middle P/E of the companies in the same sector on the same stock exchange, as the data vendor works it out each day.
What does a cash-flow model say a share is worth?
A standard cash-flow model puts it at $9 a share — 39% below the $14.41 price it was computed against (27 Oct).
| Model | Value a share | Against the price then |
|---|---|---|
| Standard | $9 | 39% below $14.41 |
| Levered | $9 | 36% below $14.41 |
Discounted cash flow: a model's estimate of what the company is worth today, from the cash it is forecast to make in future years. Small changes in the forecast move it a lot, and it says little about a company that loses money.
Standard / levered: two versions of the cash-flow model: the standard one counts the cash before the company pays its lenders, the levered one after.